BIOHITECH GLOBAL INC (BHTG)

Common Stock

0.837  -0.01 (-1.54%)

After market: 0.837 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BHTG. BHTG was compared to 85 industry peers in the Commercial Services & Supplies industry. BHTG may be in some trouble as it scores bad on both profitability and health. BHTG is valued quite expensively, but it does show have an excellent growth rating.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BHTG has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -14.64%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -54.81%
PM (TTM) -60.71%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for BHTG has been increased compared to 1 year ago.
Compared to 1 year ago, BHTG has a worse debt to assets ratio.

2.2 Solvency

BHTG has an Altman-Z score of -1.97. This is a bad value and indicates that BHTG is not financially healthy and even has some risk of bankruptcy.
BHTG has a Debt/Equity ratio of 5.04. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 5.04
Debt/FCF N/A
Altman-Z -1.97
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.42 indicates that BHTG may have some problems paying its short term obligations.
A Quick Ratio of 0.37 indicates that BHTG may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.37

More info and screens

7

3. Growth

3.1 Past

BHTG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.59%, which is quite impressive.
Looking at the last year, BHTG shows a very strong growth in Revenue. The Revenue has grown by 208.64%.
The Revenue has been growing by 31.24% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)35.59%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q33.33%
Revenue 1Y (TTM)208.64%
Revenue growth 3Y34.44%
Revenue growth 5Y31.24%
Revenue growth Q2Q511.26%

3.2 Future

The Earnings Per Share is expected to grow by 11.11% on average over the next years. This is quite good.
The Revenue is expected to grow by 53.86% on average over the next years. This is a very strong growth
EPS Next Y46.66%
EPS Next 2Y24.68%
EPS Next 3Y22.58%
EPS Next 5Y11.11%
Revenue Next Year160.6%
Revenue Next 2Y59.88%
Revenue Next 3Y66.05%
Revenue Next 5Y53.86%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BHTG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BHTG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -11.32

4.3 Compensation for Growth

BHTG's earnings are expected to grow with 22.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.68%
EPS Next 3Y22.58%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BHTG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIOHITECH GLOBAL INC

NASDAQ:BHTG (12/10/2021, 7:56:33 PM)

After market: 0.837 0 (0%)

0.837

-0.01 (-1.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap23.84M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.64%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -54.81%
PM (TTM) -60.71%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 5.04
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.42
Quick Ratio 0.37
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)35.59%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y46.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)208.64%
Revenue growth 3Y34.44%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y